Results 211 to 220 of about 539,134 (347)

Donor selection and surgical technique for en bloc liver-small bowel graft procurement [PDF]

, 1993
Abu-Elmagd, K, Casavilla, A, Selby, R, Starzl, TE, Todo, S, Tzakis, A   +5 more
core  

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

Molecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu, Katherine Eason, Suet‐Feung Chin, Paul A. W. Edwards, Raquel Manzano Garcia, Richard Moulange, Jia Wern Pan, Soo Hwang Teo, Sach Mukherjee, Maurizio Callari, Carlos Caldas, Stephen‐John Sammut, Oscar M. Rueda   +12 more
wiley   +1 more source

High-Throughput Screening Assay for Convalescent Sera in COVID-19: Efficacy, Donor Selection, and Variant Neutralization. [PDF]

Microorganisms
Kota KP, Trakht I, Kalantarov G, Ordonez D, Wei J, Trefry S, Bavari E, Richardson J, Zamani R, Raney C, Nasar F, Daugherty B, Lederman S, Bavari S.   +13 more
europepmc   +1 more source

The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis

, 2003
Joke I. Roodnat, I. C. van Riemsdijk, Paul Mulder, Ilias I.N. Doxiadis, Frans H.J. Claas, Jan N.M. IJzermans, Teun van Gelder, Willem Weimar   +7 more
openalex   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. [PDF]

J Hematol Oncol, 2021
Zhang XH, Chen J, Han MZ, Huang H, Jiang EL, Jiang M, Lai YR, Liu DH, Liu QF, Liu T, Ren HY, Song YP, Sun ZM, Tang XW, Wang JM, Wu DP, Xu LP, Zhang X, Zhou DB, Huang XJ.   +19 more
europepmc   +1 more source

Selection and management of the embryo transfer donor mare

, 2003
Tom A. E. Stout
openalex   +2 more sources

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

Selection of lowly immunogenic and highly tolerogenic donor and recipient allochimeric class I major histocompatibility complex proteins

, 2003
John L. Perez, Stanislaw M. Stepkowski, Ping Song, Barton W Trawick, Mouer Wang, S. Janczewska, Barry D. Kahan   +6 more
openalex   +1 more source

RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management [PDF]

, 2010
Ross M. Fasano, Alessandro Monaco, Emily Riehm Meier, Philippe Pary, A. Hallie Lee‐Stroka, John Otridge, Harvey G. Klein, Francesco M. Marincola, Naynesh Kamani, Naomi L.C. Luban, David F. Stroncek, Willy A. Flegel   +11 more
openalex   +1 more source